SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 26.17 |
| Enterprise Value ($M) | 3.39 |
| Book Value ($M) | 25.63 |
| Book Value / Share | 1.92 |
| Price / Book | 1.02 |
| NCAV ($M) | 19.48 |
| NCAV / Share | 1.46 |
| Price / NCAV | 1.34 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.66 |
| Return on Assets (ROA) | -1.54 |
| Return on Equity (ROE) | -2.70 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.67 |
| Current Ratio | 7.67 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 23.77 |
| Assets | 29.91 |
| Liabilities | 4.28 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | -63.17 | |
| 13G | Intracoastal Capital, Llc | 4.99 | ||
| 13D/A | Hare Joshua | 25.70 | -86.42 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 69,926 | 240,952 | 29.02 | |
| 143,651 | 381,203 | 37.68 | |
| 42,831 | 189,099 | 22.65 | |
| 65,319 | 261,371 | 24.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KZR – Kezar Life Sciences, Inc. | LEXX – Lexaria Bioscience Corp. |
| LFVN – LifeVantage Corporation | LIPO – Lipella Pharmaceuticals Inc. |
| LIXT – Lixte Biotechnology Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io